Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Eduardas Aleknavičius:

Search results

Items: 1 to 20 of 30

1.

Impact of season of diagnosis on mortality among breast cancer survivors.

Kuzmickiene I, Atkocius V, Aleknavicius E, Ostapenko V.

J Cancer Res Ther. 2018 Dec;14(Supplement):S1091-S1097. doi: 10.4103/0973-1482.191064.

2.

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.

Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators.

Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Erratum in: Lancet. 2019 Jan 12;393(10167):132.

PMID:
30509740
3.

Acute toxicity and quality of life in high risk prostate cancer patients: Updated results of randomized hypofractionation trial.

Karklelyte A, Valuckas KP, Griskevicius R, Janulionis E, Aleknavicius E.

Rep Pract Oncol Radiother. 2018 Jul-Aug;23(4):284-289. doi: 10.1016/j.rpor.2018.06.008. Epub 2018 Jul 26.

4.

Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.

Baltruskeviciene E, Schveigert D, Stankevicius V, Mickys U, Zvirblis T, Bublevic J, Suziedelis K, Aleknavicius E.

BMC Cancer. 2017 Sep 1;17(1):607. doi: 10.1186/s12885-017-3575-z.

5.

Changes of reduced glutathione and glutathione S-transferase levels in colorectal cancer patients undergoing treatment.

Baltruskeviciene E, Kazbariene B, Aleknavicius E, Krikstaponiene A, Venceviciene L, Suziedelis K, Stratilatovas E, Didziapetriene J.

Tumori. 2018 Oct;104(5):375-380. doi: 10.5301/tj.5000674. Epub 2018 May 8.

PMID:
28777429
6.

Microenvironment and Dose-Delivery-Dependent Response after Exposure to Ionizing Radiation in Human Colorectal Cancer Cell Lines.

Stankevicius V, Vasauskas G, Rynkeviciene R, Venius J, Pasukoniene V, Aleknavicius E, Suziedelis K.

Radiat Res. 2017 Sep;188(3):291-302. doi: 10.1667/RR14658.1. Epub 2017 Jul 7.

PMID:
28686531
7.

Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

Samalavicius NE, Dulskas A, Baltruskeviciene E, Smailyte G, Skuciene M, Mikelenaite R, Venslovaite R, Aleknavicius E, Samalavicius A, Lunevicius R.

Wideochir Inne Tech Maloinwazyjne. 2016;11(4):274-282. doi: 10.5114/wiitm.2016.64981. Epub 2016 Dec 31.

8.

Glutathione and glutathione S-transferase levels in patients with liver metastases of colorectal cancer and other hepatic disorders.

Baltruskeviciene E, Kazbariene B, Badaras R, Bagdonaitė L, Krikštaponienė A, Zdanavičius L, Aleknavicius E, Didziapetrienė J.

Turk J Gastroenterol. 2016 Jul;27(4):336-41. doi: 10.5152/tjg.2016.15457.

9.

Erratum to: Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.

Usinskiene J, Ulyte A, Bjørnerud A, Venius J, Katsaros VK, Rynkeviciene R, Letautiene S, Norkus D, Suziedelis K, Rocka S, Usinskas A, Aleknavicius E.

Neuroradiology. 2016 Jul;58(7):741. No abstract available.

PMID:
27209419
10.

Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.

Usinskiene J, Ulyte A, Bjørnerud A, Venius J, Katsaros VK, Rynkeviciene R, Letautiene S, Norkus D, Suziedelis K, Rocka S, Usinskas A, Aleknavicius E.

Neuroradiology. 2016 Apr;58(4):339-50. doi: 10.1007/s00234-016-1642-9. Epub 2016 Jan 15. Review. Erratum in: Neuroradiology. 2016 Jul;58(7):741.

PMID:
26767528
11.

Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience.

Baltruškevičienė E, Mickys U, Žvirblis T, Stulpinas R, Pipirienė Želvienė T, Aleknavičius E.

Acta Med Litu. 2016;23(1):24-34. doi: 10.6001/actamedica.v23i1.3267.

12.

Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.

Grybauskas M, Daisne JF, Aleknavičius E, Burneckis A.

Medicina (Kaunas). 2014;50(4):245-8. doi: 10.1016/j.medici.2014.09.003. Epub 2014 Sep 29.

13.

Postmastectomy internal mammary nodal irradiation: a long-term outcome.

Aleknavičius E, Atkočius V, Kuzmickienė I, Steponavičienė R.

Medicina (Kaunas). 2014;50(4):230-6. doi: 10.1016/j.medici.2014.09.010. Epub 2014 Oct 7.

14.

The significance of reduced glutathione and glutathione S-transferase during chemoradiotherapy of locally advanced cervical cancer.

Daukantienė L, Kazbarienė B, Valuckas KP, Didžiapetrienė J, Krikštaponienė A, Aleknavičius E.

Medicina (Kaunas). 2014;50(4):222-9. doi: 10.1016/j.medici.2014.09.005. Epub 2014 Oct 1.

15.

Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.

Juozaitytė E, Aleknavičius E, Jančiauskienė R, Cesas A, Pipirienė-Želvienė T, Liutkauskienė S, Krasauskienė A, Vencevičienė L.

Medicina (Kaunas). 2014;50(4):197-203. doi: 10.1016/j.medici.2014.09.004. Epub 2014 Oct 1.

16.

Rare types of breast carcinoma.

Gudaviciene D, Steponaviciene L, Meskauskas R, Smailyte G, Aleknavicius E.

Open Med (Wars). 2014 Nov 24;10(1):92-96. doi: 10.1515/med-2015-0016. eCollection 2015.

17.

Rhabdoid carcinoma of the rectum.

Samalavicius NE, Stulpinas R, Gasilionis V, Baltruskeviciene E, Aleknavicius E, Mickys U.

Ann Coloproctol. 2013 Dec;29(6):252-5. doi: 10.3393/ac.2013.29.6.252. Epub 2013 Dec 31.

18.

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.

Norkus D, Karklelyte A, Engels B, Versmessen H, Griskevicius R, De Ridder M, Storme G, Aleknavicius E, Janulionis E, Valuckas KP.

Radiat Oncol. 2013 Sep 4;8:206. doi: 10.1186/1748-717X-8-206.

19.

Second malignancies following conventional or combined ²⁵²Cf neutron brachytherapy with external beam radiotherapy for breast cancer.

Valuckas KP, Atkocius V, Kuzmickiene I, Aleknavicius E, Liukpetryte S, Ostapenko V.

J Radiat Res. 2013 Sep;54(5):872-9. doi: 10.1093/jrr/rrt009. Epub 2013 Feb 7.

20.

Targeted therapy in patients with non-small cell lung cancer previously treated with chemotherapy.

Drobnienė M, Cicėnienė A, Zelvienė TP, Grigienė R, Lachej N, Steponavičienė L, Aleknavičius E.

Medicina (Kaunas). 2011;47(9):520-5. Epub 2011 Dec 2.

Supplemental Content

Loading ...
Support Center